Drug Shortage Report for CEFTRIAXONE SODIUM FOR INJECTION BP

Last updated on 2021-04-06 History
Report ID 124615
Drug Identification Number 02250306
Brand name CEFTRIAXONE SODIUM FOR INJECTION BP
Common or Proper name Ceftriaxone Sodium for Injection, BP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) CEFTRIAXONE
Strength(s) 2G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 x 2g vial
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-09-30
Estimated end date
Actual end date 2021-04-05
Shortage status Resolved
Updated date 2021-04-06
Company comments Item is discontinued.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-04-06 English Compare
v7 2021-04-05 French Compare
v6 2021-04-05 English Compare
v5 2021-04-05 French Compare
v4 2021-04-05 English Compare
v3 2020-10-01 English Compare
v2 2020-09-21 French Compare
v1 2020-09-21 English Compare